BEDFORD MEMORIAL HOSPITAL
1. Target Overview & Investment Thesis
BEDFORD MEMORIAL HOSPITAL is a 33-bed suburban community hospital in BEDFORD, VA with $47.8M in net patient revenue and a 6.2% operating margin. The hospital serves a payer mix of 46.7% Medicare, 3.6% Medicaid, and 49.7% commercial.
Thesis: Turnaround. Our ML models identify $3.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.2% to 13.6% (+736bps).
| Net Revenue HCRIS | $47.8M |
| Current EBITDA COMPUTED | $3.0M |
| Operating Margin COMPUTED | 6.2% |
| Occupancy HCRIS | 49.7% |
| Revenue / Bed COMPUTED | $1.4M |
| Net-to-Gross HCRIS | 26.6% |
| Distress Probability ML | 47.9% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 6.2% places it above the state median. Among 37 size-comparable peers (16-66 beds), the median margin is 1.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (16-66), prioritizing same-state peers. 37 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BEDFORD MEMORIAL HOSPITAL (Target) | VA | 33 | $47.8M | 6.2% |
| LONESOME PINE HOSPITAL | VA | 56 | $175.6M | 17.2% |
| COMMUNITY MEMORIAL HOSPITAL | VA | 66 | $135.2M | -31.0% |
| STAFFORD HOSPITAL | VA | 61 | $127.9M | 5.7% |
| HALIFAX REGIONAL HOSPITAL | VA | 44 | $104.6M | -16.5% |
| SHORE MEMORIAL HOSPITAL | VA | 52 | $103.1M | 11.4% |
| WARREN MEMORIAL HOSPITAL | VA | 46 | $97.7M | -6.4% |
| UVA HEALTH HAYMARKET MEDICAL C | VA | 44 | $95.4M | 13.4% |
| SHENANDOAH MEMORIAL HOSPITAL | VA | 25 | $78.2M | 7.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.0M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $957K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $947K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $582K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $31K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $3.0M |
| + RCM Uplift | +$3.5M |
| Pro Forma EBITDA | $6.5M |
| Current Margin | 6.2% |
| Pro Forma Margin | 13.6% |
| WC Released (1x) | $1.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $4.6M | $54.9M | 11.95x | 64.2% |
| Base (11x exit) | 10.0x | 11.0x | $4.6M | $61.9M | 13.47x | 68.2% |
| Bull Case | 9.0x | 11.0x | $4.1M | $75.0M | 18.13x | 78.5% |
| Bull (12x exit) | 9.0x | 12.0x | $4.1M | $83.1M | 20.08x | 82.2% |
| Bear Case | 11.0x | 10.0x | $5.1M | $35.8M | 7.08x | 47.9% |
| Bear (11x exit) | 11.0x | 11.0x | $5.1M | $41.0M | 8.12x | 52.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 37 hospitals with 16-66 beds
- Same-state prioritization (n=38)
- Comp margins: P25=-12.9% / P50=1.3% / P75=15.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.